The tumor inflammation signature (TIS) is comprised of 18 genes (Table S9) and is used to indicate the level of suppression of adaptive immunity in tumors and differentiate response to the checkpoint anti-PD-1 treatment (where PD-1 is encoded in the Programmed Cell Death 1 [PDCD1] gene) [42]. The gene discussed is PDCD1; the disease is neoplasm.